Share Twitter LinkedIn Facebook Email Shyamala Navada, MD, MSCR, Associate Professor, Hematology and Medical Oncology, @MountSinaiNYC @IcahnMountSinai elaborates on the current approaches to treating elderly patients with myeloid malignancies.
Asciminib: ASH 2022 Prof. Tim Hughes Studies For patients With CML Chronic Myelogenous Leukemia 7 Mins Read